India  

DNA Explainer: Why Bharat Biotech's Covaxin is costlier that other vaccines

DNA Wednesday, 16 June 2021
Bharat Biotech stated that less than 10% of Covaxin was supplied to private hospitals and the remaining was supplied to state and Central governments.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News [Video]

Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News

Covaxin maker Bharat Biotech has claimed that the vaccine is 77.8% effective overall against Covid-19 after analysing results for its phase 3 trials. Bharat Biotech also claimed that Covaxin provides..

Credit: Oneindia     Duration: 02:13Published
Zydus Cadila caps clinical trials of DNA vaccine for minors | Vaccines for children | Oneindia News [Video]

Zydus Cadila caps clinical trials of DNA vaccine for minors | Vaccines for children | Oneindia News

Yesterday, the Centre informed the Supreme Court that Zydus Cadila, which is developing a DNA vaccine, has completed its clinical trials for the 12 to 18 age group. The government added that the Drugs..

Credit: Oneindia     Duration: 01:29Published
Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News [Video]

Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News

Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 according to data from Phase III trials conducted on 25,800 participants across India. The data was submitted to the..

Credit: Oneindia     Duration: 02:03Published